Star Therapeutics Stock

www.star-therapeutics.com/Healthcare / BioTech & PharmaFounded: 2018

Star Therapeutics, founded in 2018, is a biotechnology company that aims to look for gaps that exist in the fields of hematology and immunology. The goal is to create life-changing antibody therapies for people who lack options for diseases that do not currently have viable treatments. Star Therapeutics looks for ways to apply the treatments to a variety of diseases and also manages a portfolio of companies. Star Therapeutics is headquartered in San Francisco, California.

Register To Buy and Sell Shares

For more details on financing and valuation for Star Therapeutics, register or login.

Please provide a valid email address.

By registering, you agree to Forge’s Terms of Use. Already registered? Log in

OverviewFinancingsValuation

Enterprise Value

Powered by Forge Data

Access Star Therapeutics’ valuation and stock price.

View secondary pricing information, VWAP and distribution waterfall. And seek potentially outsized returns with same day private market data for private companies like Star Therapeutics.

Become part of the Secondary Marketplace, catering to both individual and institutional investors.

Register

Animation displayed is not current and securities are shown for illustrative purposes only.

Star Therapeutics investors also invested in these private companies

New Leaf Venture Partners
Westlake Village BioPartners
NYBC Ventures

Team

Management Team

Kathy Dong
Chief Operating Officer
Sandip Panicker Ph.D
Chief Scientific Officer
Jeremy Boucher
Vice President & Head of Finance
Adam Rosenthal Ph.D
Founder, Chief Executive Officer, & President
Gary Patou MD
Chief Medical Officer

Board Members

Carl Gordon Ph.D
OrbiMed
Nancy Stagliano Ph.D
New Leaf Venture
Vijay Lathi
New Leaf Venture

Star Therapeutics’ stock FAQs

plusminus

Can you buy Star Therapeutics’ stock?

Star Therapeutics is not publicly traded on NYSE or NASDAQ in the U.S. To buy Star Therapeutics’ stock you need to be an accredited investor. Learn more about how to invest in the private market or register today to get started.
plusminus

Can you sell Star Therapeutics’ stock?

Yes, you can sell stock of a private company like Star Therapeutics. Forge can help you sell your Star Therapeutics stock in a way that works for you and the company. So if you are seeking liquidity, register with us today to get started.
plusminus

What is Star Therapeutics’ stock price?

Star Therapeutics is a privately held company and therefore does not have a public stock price. However, you may access Star Therapeutics’ private market stock price with Forge Data.
plusminus

What is Star Therapeutics’ stock ticker symbol?

Star Therapeutics does not have an official ticker symbol because this company is not currently publicly traded.
plusminus

Can institutional investors buy and sell private market stocks?

Yes. As one of the largest trading platform for the private market, Forge helps institutional investors seek liquidity as they buy and sell private stock for their portfolios or their clients. Our private market specialists have decades of experience working with institutional firms. Learn more or register today to get started.

News Highlights

Investors shower Star Therapeutics with $90M for constellation of biotechs, antibody therapies

Investors have showered Star Therapeutics with $90 million to grow its portfolio companies and develop new antibody drugs for diseases with high unmet need. Sofinnova Investments led the oversubscribed series C round and was joined by new investors Qatar Investment Authority, Catalio Capital Management, Agent Capital, Soleus Capital and NYBC Ventures alongside all seven existing investors. The new funds nearly double the $100 million Star had already raised since its founding in late 2018.
Updated on: Jul 17, 2024

PLEASE READ THESE IMPORTANT LEGAL NOTICES & DISCLOSURES

Public news articles listed on this page have been curated by Forge based on several factors including, but not limited to, product updates, changes in organization structure, funding rounds, third-party valuations, and key personnel changes. Changes to this list of articles can be made at any time without notice and should not be relied upon for investment purposes. Forge does not verify the accuracy of the information contained in public news articles.